IJMS | Free Full-Text | CA 19-9 Pancreatic Tumor Marker Fluorescence Immunosensing Detection via Immobilized Carbon Quantum Dots Conjugated Gold Nanocomposite
Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases | Scientific Reports
Combined Evaluation of AFP, CA15-3, CA125, CA19-9, and CEA Tumor Markers in Patients with Hepatitis B and C | Semantic Scholar
Old Dog, New Tricks: Use of CA 19-9 for Early Diagnosis of Pancreatic Cancer - Gastroenterology
Common benign HPB conditions with associated deranged CA19.9 level | Download Table
Tumor Marker Screening For Men & Women At IDC
The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal - Ballehaninna - Journal of Gastrointestinal Oncology
Should I take a Cancer Marker Test? | Positive Bioscience
![PDF] False-positive elevations of carcinoembryonic antigen in patients with a history of resected colorectal cancer. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1144a56968788915c60eb298e39fcf2d60c86823/5-Table2-1.png "PDF] False-positive elevations of carcinoembryonic antigen in patients with a history of resected colorectal cancer. | Semantic Scholar")
PDF] False-positive elevations of carcinoembryonic antigen in patients with a history of resected colorectal cancer. | Semantic Scholar
Dynamic change of serum CA19–9 levels in benign and malignant patients with obstructive jaundice after biliary drainage and new correction formulas | BMC Cancer | Full Text
Biomolecular recognition of the glycan neoantigen CA19-9 by distinct antibodies | bioRxiv
The glycan CA19-9 promotes pancreatitis and pancreatic cancer in mice | Science
Diagnostic and prognostic value of carcinoembryonic antigen in pancrea | OTT
TUMOR MARKERS OF COLORECTAL CARCINOMA
Carbohydrate antigen 19-9 — tumor marker: Past, present, and future
Persistent increase of carbohydrate antigen 19‐9 with an unknown reason: A seven‐year follow‐up case - Zhao - Journal of Clinical Laboratory Analysis - Wiley Online Library
The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal - Ballehaninna - Journal of Gastrointestinal Oncology
Gene Variants That Affect Levels of Circulating Tumor Markers Increase Identification of Patients With Pancreatic Cancer - ScienceDirect
Persistent elevation of Ca 19-9 and an unexpected finding. A case report | Cirugía y Cirujanos (English Edition)
Tumor Markers : All you need to know
Two Patients with Extremely Elevated Tumor Markers: Where Is the Malignancy?
Enhanced Discrimination of Malignant from Benign Pancreatic Disease by Measuring the CA 19-9 Antigen on Specific Protein Carriers | PLOS ONE
Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagent induction chemotherapy: results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113)☆ - ESMO Open
